Abstract

Based on the experience of performing endomyocardial biopsy and the results of its histological diagnosis and treatment, as well as the continuous development of medical technology and diagnosis of non-coronary myocardial diseases in modern realities, myocardial biopsy still remains the "gold standard" of diagnosis. Endomyocardial biopsy is an invasive diagnostic method, therefore, it has periprocedural and postprocedural risks associated with both endovascular access to the heart and biopsy performance. This article describes the history of endomyocardial biopsy and a clinical case complicated by extravasation into the fascial bed of the sternocleidomastoid muscle, as well as strategies and methods that can improve the sensitivity of endomyocardial biopsy using additional instrumental diagnostic methods.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call